NCT03694158 Investigating Dupilumab's Effect in Asthma by Genotype Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03687359 Observational Evaluation of Atopic Dermatitis in Pediatric Patients Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03684642 Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Status TERMINATED Phase PHASE3
NCT03682770 Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy) Status COMPLETED Phase PHASE2
NCT03681158 Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female Subjects Status COMPLETED Phase PHASE1
NCT03664882 Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants Status COMPLETED Phase PHASE3
NCT03660839 Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria Status COMPLETED Phase PHASE2
NCT03637764 Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT03634982 Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors Status UNKNOWN Phase PHASE1
NCT03634293 Treatment of Severe Infection With Antihyperlipidemia Drug Status UNKNOWN Phase PHASE2/PHASE3
NCT03633617 Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) Status COMPLETED Phase PHASE3
NCT03620747 Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up) Status COMPLETED Phase PHASE3
NCT03600818 Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica Status TERMINATED Phase PHASE3
NCT03600805 Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA Status TERMINATED Phase PHASE3
NCT03596398 Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients Status UNKNOWN Phase N/A
NCT03594955 First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome Status TERMINATED Phase PHASE1/PHASE2
NCT03583658 Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis Status COMPLETED Phase PHASE3
NCT03560466 Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) Status COMPLETED Phase PHASE3
NCT03559309 Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia Status TERMINATED Phase PHASE4
NCT03558997 Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy Status COMPLETED Phase PHASE2